Clinical observation of cardiac function in patients with acute myocardial infarction complicated with heart failure undergoing stem cell transplantation: a 2-year follow-up visit

doi:10.3969/j.issn.2095-4344.2014.19.016

Abstract

Abstract:

BACKGROUND: Many animal experiments and clinical trials have demonstrated that stem cell transplantation can improve heart function and reduce ventricular dilatation and ventricular remodeling, which has shown an incomparable superiority over traditional therapies in the treatment of myocardial infarction complicated by heart failure.
OBJECTIVE: To observe the clinical effects of single autologous peripheral blood stem cell transplantation in acute myocardial infarction patients with heart failure.
METHODS: Since 2006 August to 2010 June, 23 patients who were diagnosed to have acute ST elevation myocardial infarction complicated with heart failure were selected and divided into two groups: cell transplantation group (n=11) and control group (n=12). All patients underwent emergency coronary angiography and percutaneous coronary intervention with drug eluting stent implantation. In the stem cell transplantation group, peripheral blood stem cells positive for CD34 (about 1×10⁸) were collected mobilized by granulocyte colony stimulating factor at 5 days after stent implantation, and then the cells were injected into infarcted vessels using coronary angiography method. Two-year follow-up was performed after cell transplantation to observe the cardiac function and adverse reactions in patients.
RESULTS AND CONCLUSION: After 6 months of follow-up, the cardiac function in the cell transplantation group was improved significantly compared with that before cell transplantation (P < 0.05), and the left ventricular ejection fraction was increased by (6.2±0.2)% and the left ventricular end diastolic volume was reduced by (4.7±2.9) mm. However, there was no difference in follow-up results by the end of 1 and 2 years after cell transplantation (P > 0.05), as well as no adverse reaction occurred. In the control group, after 6 months of follow-up, the left ventricular ejection fraction was reduced by (0.5±0.1)% and the left ventricular end diastolic volume was increased by (0.4±0.3) mm, which were deteriorated year after year. Percutaneous coronary intervention with autologous peripheral blood stem cell transplantation can significantly improve the left ventricular function, reduce left ventricular volume, and delay or prevent left ventricular remodeling in patients with acute myocardial infarction, which is safe and effective. But up to 2 years after cell transplantation, the cardiac function shows no further improvement.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

全文链接：

Key words: myocardial infarction, heart failure, stem cell transplantation, peripheral blood stem cell transplantation, stroke volume

CLC Number:

R394.2

Chen Xiao-ming, Yang Zhi-yong, Cui Dan-yang, Zhang Ming. Clinical observation of cardiac function in patients with acute myocardial infarction complicated with heart failure undergoing stem cell transplantation: a 2-year follow-up visit[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(19): 3048-3053.

Figures/Tables 4

References

[1] Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829): 701-705.
[2] [M K, M T, S G, et al. Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia. J Stem Cells Regen Med. 2012;8(3):171-180.
[3] Li TS, Hayashi M, Ito H, et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation. 2005;111(19):2438-2445.
[4] Orlic D, Kajstura J, Chimenti S, et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant. 2003;7 Suppl 3:86-88.
[5] Kang HJ, Lee HY, Na SH, ET AL. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation. 2006 Jul 4;114(1 Suppl):I145-151.
[6] Kang HJ, Kim HS, Koo BK, et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J. 2007;153(2): 237.e1-8.
[7] Tse HF, Thambar S, Kwong YL, et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J. 2007;28(24): 2998-3005.
[8] Yin ZM, Li CJ, Wang Y, et al. Improvement of leR ventricular function by intracoronary transplantation of autologous bone marrow stem cell in patients with acute myocardial infarction. Zhongguo Yiyao. 2010;5(9):785-787.
[9] Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364(9429):141-148.
[10] Chu YY, Zhang WZ, Chen YQ, et al. Experimental study on adipose tissue-derived mesenchymal stem cells transplantation for Treatment of acute myocardial infarction in rabitbits. Lingnan Xinxueguanbing Zazhi. 2010;26(2): 147-153.
[11] Xing YL, Liu JH, Li M, et al. Effects of CD34+ human umbilical cord blood cell transplantation in different time on cardiac function and vascular endothelial cell growth factor secrection in rats with myocardial infarction. Zhongguo Zuzhi Gongcheng Yanjiu. 2012;16(23):4267-4272.
[12] Zhang X, Zhang T, Li W, et al. Assessment of left ventricular remodeling and cardiac function by echocardiography after transplantation of autologous peripheral blood stem cells in patients with myocardial infarction complicated cardiac inadequacy. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2008;12(21):4111-4114.
[13] Gu X, Xu HT, Li MH, et al. Efficiency and safety of peripheral blood stem cells transplantation in elderly patients with heart failure after myocardial infarction. Zhonghua Laonian Duoqiguan Jibing Zazhi. 2009;8(5): 420-424.
[14] Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367(9505): 113-121.
[15] Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;2:CD006536.
[16] Clifford DM, Fisher SA, Brunskill SJ, et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS One. 2012;7(5):e37373.
[17] Poh KK, Sperry E, Young RG, et al. Transplantation of allogeneic mesenchymal stem cells:safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy. Int J Cardiol. 2007;117(3):360-364
[18] Hu YG. Stem cell transplantation for ischemic heart disease: Clinical feasibility and safety. Zhongguo Zuzhi Gongcheng Yanjiu. 2013;17(32): 5889-5894.